Skip to content

Clinical trials

Observational Carcinoma, Squamous Cell trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Squamous Cell Phase: Observational Country / region: United States Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20041
20053
20064
20072
20081
20094
20102
20121
20131
20141
20152
20163
20171
20181
20193
20204
20222
20233
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Terminated5
Unknown status5
Recruiting4
Active, not recruiting3
Withdrawn3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Memorial Sloan Kettering Cancer Center5
Mayo Clinic3
Stanford University3
Icahn School of Medicine at Mount Sinai2
M.D. Anderson Cancer Center2
Massachusetts General Hospital2
National Institute on Deafness and Other Communication Disorders (NIDCD)2
Northwestern University2
UNC Lineberger Comprehensive Cancer Center2
Abramson Cancer Center at Penn Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Squamous Cell45
Basal Cell Carcinoma16
Head and Neck Neoplasms11
Melanoma11
Skin Neoplasms10
Adenocarcinoma7
Squamous Cell Carcinoma of Head and Neck5
Carcinoma4
Carcinoma, Non-Small-Cell Lung4
Laryngeal Neoplasms4

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.